BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36618935)

  • 1. A
    Veale EL; Golluscio A; Grand K; Graham JM; Mathie A
    Front Pharmacol; 2022; 13():1093313. PubMed ID: 36618935
    [No Abstract]   [Full Text] [Related]  

  • 2. Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant.
    Hawkins NA; Misra SN; Jurado M; Kang SK; Vierra NC; Nguyen K; Wren L; George AL; Trimmer JS; Kearney JA
    Neurobiol Dis; 2021 Jan; 147():105141. PubMed ID: 33132203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion selectivity, expression, and localization.
    Thiffault I; Speca DJ; Austin DC; Cobb MM; Eum KS; Safina NP; Grote L; Farrow EG; Miller N; Soden S; Kingsmore SF; Trimmer JS; Saunders CJ; Sack JT
    J Gen Physiol; 2015 Nov; 146(5):399-410. PubMed ID: 26503721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered neurological and neurobehavioral phenotypes in a mouse model of the recurrent
    Kang SK; Hawkins NA; Echevarria-Cooper DM; Baker EM; Dixon CJ; Speakes N; Kearney JA
    bioRxiv; 2023 Mar; ():. PubMed ID: 37034689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNB1 frameshift variant caused inherited intellectual disability, developmental delay, and seizure.
    Uctepe E; Esen FN; Tümer S; Mancılar H; Yeşilyurt A
    Intractable Rare Dis Res; 2022 Nov; 11(4):219-221. PubMed ID: 36457583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes.
    de Kovel CGF; Syrbe S; Brilstra EH; Verbeek N; Kerr B; Dubbs H; Bayat A; Desai S; Naidu S; Srivastava S; Cagaylan H; Yis U; Saunders C; Rook M; Plugge S; Muhle H; Afawi Z; Klein KM; Jayaraman V; Rajagopalan R; Goldberg E; Marsh E; Kessler S; Bergqvist C; Conlin LK; Krok BL; Thiffault I; Pendziwiat M; Helbig I; Polster T; Borggraefe I; Lemke JR; van den Boogaardt MJ; Møller RS; Koeleman BPC
    JAMA Neurol; 2017 Oct; 74(10):1228-1236. PubMed ID: 28806457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo KCNB1 mutations in epileptic encephalopathy.
    Torkamani A; Bersell K; Jorge BS; Bjork RL; Friedman JR; Bloss CS; Cohen J; Gupta S; Naidu S; Vanoye CG; George AL; Kearney JA
    Ann Neurol; 2014 Oct; 76(4):529-540. PubMed ID: 25164438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo KCNB1 mutations in infantile epilepsy inhibit repetitive neuronal firing.
    Saitsu H; Akita T; Tohyama J; Goldberg-Stern H; Kobayashi Y; Cohen R; Kato M; Ohba C; Miyatake S; Tsurusaki Y; Nakashima M; Miyake N; Fukuda A; Matsumoto N
    Sci Rep; 2015 Oct; 5():15199. PubMed ID: 26477325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel de novo KCNB1 variant altering channel characteristics in a patient with periventricular heterotopia, abnormal corpus callosum, and mild seizure outcome.
    Hiraide T; Akita T; Uematsu K; Miyamoto S; Nakashima M; Sasaki M; Fukuda A; Kato M; Saitsu H
    J Hum Genet; 2023 Jan; 68(1):25-31. PubMed ID: 36257979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel KCNB1 mutation associated with non-syndromic intellectual disability.
    Latypova X; Matsumoto N; Vinceslas-Muller C; Bézieau S; Isidor B; Miyake N
    J Hum Genet; 2017 Apr; 62(5):569-573. PubMed ID: 27928161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature.
    Bar C; Barcia G; Jennesson M; Le Guyader G; Schneider A; Mignot C; Lesca G; Breuillard D; Montomoli M; Keren B; Doummar D; Billette de Villemeur T; Afenjar A; Marey I; Gerard M; Isnard H; Poisson A; Dupont S; Berquin P; Meyer P; Genevieve D; De Saint Martin A; El Chehadeh S; Chelly J; Guët A; Scalais E; Dorison N; Myers CT; Mefford HC; Howell KB; Marini C; Freeman JL; Nica A; Terrone G; Sekhara T; Lebre AS; Odent S; Sadleir LG; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
    Hum Mutat; 2020 Jan; 41(1):69-80. PubMed ID: 31513310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of K
    Kang SK; Vanoye CG; Misra SN; Echevarria DM; Calhoun JD; O'Connor JB; Fabre KL; McKnight D; Demmer L; Goldenberg P; Grote LE; Thiffault I; Saunders C; Strauss KA; Torkamani A; van der Smagt J; van Gassen K; Carson RP; Diaz J; Leon E; Jacher JE; Hannibal MC; Litwin J; Friedman NR; Schreiber A; Lynch B; Poduri A; Marsh ED; Goldberg EM; Millichap JJ; George AL; Kearney JA
    Ann Neurol; 2019 Dec; 86(6):899-912. PubMed ID: 31600826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a
    Calhoun JD; Vanoye CG; Kok F; George AL; Kearney JA
    Neurol Genet; 2017 Dec; 3(6):e198. PubMed ID: 29264390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies.
    Veeramah KR; Johnstone L; Karafet TM; Wolf D; Sprissler R; Salogiannis J; Barth-Maron A; Greenberg ME; Stuhlmann T; Weinert S; Jentsch TJ; Pazzi M; Restifo LL; Talwar D; Erickson RP; Hammer MF
    Epilepsia; 2013 Jul; 54(7):1270-81. PubMed ID: 23647072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation Analyses of Clinical Manifestations and Variant Effects in
    Xiong J; Liu Z; Chen S; Kessi M; Chen B; Duan H; Deng X; Yang L; Peng J; Yin F
    Front Pediatr; 2021; 9():755344. PubMed ID: 35071126
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrin-KCNB1 potassium channel complexes regulate neocortical neuronal development and are implicated in epilepsy.
    Bortolami A; Yu W; Forzisi E; Ercan K; Kadakia R; Murugan M; Fedele D; Estevez I; Boison D; Rasin MR; Sesti F
    Cell Death Differ; 2023 Mar; 30(3):687-701. PubMed ID: 36207442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo variants in KCNA3 cause developmental and epileptic encephalopathy.
    Soldovieri MV; Ambrosino P; Mosca I; Servettini I; Pietrunti F; Belperio G; ; Syrbe S; Taglialatela M; Lemke JR
    Ann Neurol; 2024 Feb; 95(2):365-376. PubMed ID: 37964487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variability of the clinical expression of KCNB1 encephalopathy].
    Púa-Torrejón RC; González-Alguacil E; Soto-Insuga V; Moreno-Cantero T; Ortiz-Cabrera NV; Pérez-Poyato MS; Ruiz Falcó-Rojas ML; García-Peñas JJ
    Rev Neurol; 2021 Nov; 73(12):403-408. PubMed ID: 34877642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes.
    Liang L; Li X; Moutton S; Schrier Vergano SA; Cogné B; Saint-Martin A; Hurst ACE; Hu Y; Bodamer O; Thevenon J; Hung CY; Isidor B; Gerard B; Rega A; Nambot S; Lehalle D; Duffourd Y; Thauvin-Robinet C; Faivre L; Bézieau S; Dure LS; Helbling DC; Bick D; Xu C; Chen Q; Mancini GMS; Vitobello A; Wang QK
    Hum Mol Genet; 2019 Sep; 28(17):2937-2951. PubMed ID: 31152168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long-term outcome.
    Bar C; Kuchenbuch M; Barcia G; Schneider A; Jennesson M; Le Guyader G; Lesca G; Mignot C; Montomoli M; Parrini E; Isnard H; Rolland A; Keren B; Afenjar A; Dorison N; Sadleir LG; Breuillard D; Levy R; Rio M; Dupont S; Negrin S; Danieli A; Scalais E; De Saint Martin A; El Chehadeh S; Chelly J; Poisson A; Lebre AS; Nica A; Odent S; Sekhara T; Brankovic V; Goldenberg A; Vrielynck P; Lederer D; Maurey H; Terrone G; Besmond C; Hubert L; Berquin P; Billette de Villemeur T; Isidor B; Freeman JL; Mefford HC; Myers CT; Howell KB; Rodríguez-Sacristán Cascajo A; Meyer P; Genevieve D; Guët A; Doummar D; Durigneux J; van Dooren MF; de Wit MCY; Gerard M; Marey I; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
    Epilepsia; 2020 Nov; 61(11):2461-2473. PubMed ID: 32954514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.